Symptomatic and incidental venous thromboembolic disease are both associated with mortality in patients with prostate cancer

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Chaturvedi, Shruti ^a   Sidana, Surbhi ^a   Elson, Paul ^a   Khorana, Alok A ^a   McCrae, Keith R ^a,b  

^a LERNER RESEARCH INSTITUTE   (United States)

^b TAUSSIG CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER STAGING; CANCER SURVIVAL; CAUSE OF DEATH; COHORT ANALYSIS; COMORBIDITY; COMPUTER ASSISTED TOMOGRAPHY; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EARLY CANCER; EVALUATION STUDY; FOLLOW UP; HUMAN; INCIDENTAL FINDING; INCIDENTAL VENOUS THROMBOEMBOLISM; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; METASTASIS; PREDICTIVE VALUE; PROSTATE CANCER; PROSTATECTOMY; RETROSPECTIVE STUDY; SYMPTOMATIC VENOUS THROMBOEMBOLISM; SYMPTOMATOLOGY; VENOUS THROMBOEMBOLISM; COMPLICATION; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; PROSTATIC NEOPLASMS; SURVIVAL; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; VENOUS THROMBOEMBOLISM;

EID: 84938119995     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094048     Document Type: Article

References (34)

1. Khorana AA (2003) Malignancy, thrombosis and Trousseau: the case for an eponym. J Thromb Haemost 1:2463-2465.
2. Heit JA (2006) The epidemiology of venous thromboembolism in the community: implications for prevention and management. J Thromb Thrombolysis 21:23-29.
3. Naess IA, Christiansen SC, Romundstad P, Cannegieter SC, Rosendaal FR, Hammerstrom J (2007) Incidence and mortality of venous thrombosis: A population-based study. J Thromb Haemost 5:692-699. (Pubitemid 46563566)
4. Prandoni P, Lensing AW, Buller HR, Cogo A, Prins MH, et al. (1992) Deep-vein thrombosis and the incidence of subsequent symptomatic cancer. N Engl J Med 327:1128-1133.
5. Sorensen HT, Mellemkjaer L, Olsen JH, Baron JA (2000) Prognosis of cancers associated with venous thromboembolism. N Engl J Med 343:1846-1850. (Pubitemid 32104130)
6. Gross CP, Galusha DH, Krumholz HM (2007) The impact of venous thromboembolism on risk of death or hemorrhage in older cancer patients. J Gen Intern Med 22:321-326. (Pubitemid 46941220)
7. Yu YB, Gau JP, Liu CY, Yang MH, Chiang SC, et al. (2012) A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost 108:225-235.
8. Gussoni G, Frasson S, La Regina M, Di Micco P, Monreal M, RIETE Investigators (2013) Three-month mortality rate and clinical predictors in patients with venous thromboembolism and cancer. Findings from the RIETE registry. Thromb Res 131:24-30.
9. Browder T, Folkman J, Pirie-Shepherd S (2000) The hemostatic system as a regulator of angiogenesis. J Biol Chem 275:1521-1524. (Pubitemid 30060762)
10. Rickles FR, Edwards RL (1983) Activation of blood coagulation in cancer: Trousseau's syndrome revisited. Blood 62:14-31. (Pubitemid 13070586)
11. Abdulkadir SA, Carvalhal GF, Kaleem Z, Kisiel W, Humphrey PA, et al. (2000) Tissue factor expression and angiogenesis in human prostate carcinoma. Hum Pathol 31:443-447. (Pubitemid 30262866)
12. Franchini M, Mannucci PM (2012) Thrombin and cancer: From molecular basis to therapeutic implications. Semin Thromb Hemost 38:95-101.
13. Hall IE, Andersen MS, Krumholz HM, Gross CP (2009) Predictors of venous thromboembolism in patients with advanced common solid cancers. J Cancer Epidemiol 2009:182521.
14. Siegel R, Naishadham D, Jemal A (2013) Cancer statistics, 2013. CA Cancer J Clin 63:11-30.
15. Browne AM, Cronin CG, English C, NiMhuircheartaigh J, Murphy JM, et al. (2010) Unsuspected pulmonary emboli in oncology patients undergoing routine computed tomography imaging. J Thorac Oncol 5:798-803.
16. Desai SR (2007) Unsuspected pulmonary embolism on CT scanning: Yet another headache for clinicians? Thorax 62:470-472.
17. O'Connell C, Razavi P, Ghalichi M, Boyle S, Vasan S, et al. (2011) Unsuspected pulmonary emboli adversely impact survival in patients with cancer undergoing routine staging multi-row detector computed tomography scanning. J Thromb Haemost 9:305-311.
18. den Exter PL, Hooijer J, Dekkers OM, Huisman MV (2011) Risk of recurrent venous thromboembolism and mortality in patients with cancer incidentally diagnosed with pulmonary embolism: A comparison with symptomatic patients. J Clin Oncol 29:2405-2409.
19. Prandoni P (2007) Links between arterial and venous disease. J Intern Med 262:341-50.
20. Prestidge T, Lee S, Harper P, Young L, Ockelford P (2012) Survival in patients with malignancy and venous thromboembolism by tumour subtype and thrombus location. Intern Med J 42:71-4.
21. Cogo A, Bernardi E, Prandoni P, Girolami B, Noventa F, et al. (1994) Acquired risk factors for deep-vein thrombosis in symptomatic outpatients. Arch Intern Med 154:164-8. (Pubitemid 24032190)
22. Libertiny G, Hands L (1999) Deep venous thrombosis in peripheral vascular disease. Br J Surg 86:907-10. (Pubitemid 29333015)
23. Carson JL, Kelley MA, Duff A, Weg JG, Fulkerson WJ, et al. (1992) The clinical course of pulmonary embolism. N Engl J Med 326:1240-5.
24. Deitcher SR (2003) Cancer-related deep venous thrombosis: clinical importance, treatment challenges, and management strategies. Semin Thromb Hemost 29:247-258.
25. Han LY, Landen CN, Jr, Kamat AA, Lopez A, Bender DP, et al. (2006) Preoperative serum tissue factor levels are an independent prognostic factor in patients with ovarian carcinoma. J Clin Oncol 24:755-761. (Pubitemid 46622042)
26. Nitori N, Ino Y, Nakanishi Y, Yamada T, Honda K, et al. (2005) Prognostic significance of tissue factor in pancreatic ductal adenocarcinoma. Clin Cancer Res 11:2531-9. (Pubitemid 40569450)
27. Vrana JA, Stang MT, Grande JP, Getz MJ (1996) Expression of tissue factor in tumor stroma correlates with progression to invasive human breast cancer: paracrine regulation by carcinoma cell-derived members of the transforming growth factor beta family. Cancer Res 56:5063-5070. (Pubitemid 26374450)
28. Zhang Y, Deng Y, Luther T, Müller M, Ziegler R, et al. (1994) Tissue factor controls the balance of angiogenic and antiangiogenic properties of tumor cells in mice. J Clin Invest 94:1320-1327. (Pubitemid 24286478)
29. Nakagawa K, Zhang Y, Tsuji H, Müller M, Ziegler R, et al. (1998) The angiogenic effect of tissue factor on tumors and wounds. Semin Thromb Hemost 24:207-210. (Pubitemid 28345727)
30. Abe K, Shoji M, Chen J, Bierhaus A, Danave I, et al. (1999) Regulation of vascular endothelial growth factor production and angiogenesis by the cytoplasmic tail of tissue factor. Proc Natl Acad Sci USA 96:8663-8668. (Pubitemid 29354848)
31. Lindholm PF, Lu Y, Adley BP, Vladislav T, Jovanovic B, et al. (2010) Role of monocyte-lineage cells in prostate cancer cell invasion and tissue factor expression. Prostate 70:1672-1682.
32. Kaushal V, Mukunyadzi P, Siegel ER, Dennis RA, Johnson DE, et al. (2008) Expression of tissue factor in prostate cancer correlates with malignant phenotype. Appl Immunohistochem Mol Morphol 16:1-6.
33. Ohta S, Wada H, Nakazaki T, Maeda Y, Nobori T, et al. (2002) Expression of tissue factor is associated with clinical features and angiogenesis in prostate cancer. Anticancer Res 22:2991-2996. (Pubitemid 36069348)
34. Guyatt GH, Akl EA, Crowther M, Gutterman DD, Schuunemann HJ, American College of Chest Physicians Antithrombotic Therapy and Prevention of Thrombosis Panel (2012) Executive summary: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 141:7S-47S.